PERHAPS A GIFT VOUCHER FOR MUM?: MOTHER'S DAY

Close Notification

Your cart does not contain any items

$400

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
Beck/Hart Publishing
06 May 2021
This handbook provides an expert overview of the law surrounding pharmaceutical, biological and chemical patents.

The topic of chemical and biological patents is of special importance in European and German patent law. The highly technical nature of patents in this area gives rise to special problems for patent lawyers in understanding, for instance, structural alterations like polymorphism and enantiomerism, which lead to a derivative of a substance that is comprised in the prior art. It is a legal question whether and under what circumstances such alterations are treated as novel, and in which cases they are part of the state of the art. Even if a substance is prior art, a new medical use can be patented. Dealing with natural occurrences of a substance is also a problem for patent law, as is the difficulty of understanding how different identifications of a substance and the resulting patents interrelate with each other. This book provides an expert overview of all these questions.

Past decisions of the European Court of Justice (ECJ) concerning broccoli and tomato patents, as well as embryonic stem cells, have highlighted the importance of this field of law. Most of the proceedings regarding chemical and biological patents have been held in German courts, and the German jurisprudence has often been the basis for ECJ decisions. Thus, German case law is used to illustrate the commentary.

By:   , , , ,
Imprint:   Beck/Hart Publishing
Country of Publication:   United Kingdom
Dimensions:   Height: 240mm,  Width: 160mm,  Spine: 16mm
Weight:   490g
ISBN:   9781849464901
ISBN 10:   1849464901
Pages:   250
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Hardback
Publisher's Status:   Active

Maximilian Haedicke is Professor of Intellectual Property Law at the University of Freiburg, Germany. Marco Stief is Director Legal in the Legal Department of Fresenius, Bad Homburg, Germany. Dirk Bühler is patent attorney and partner in Maiwald Patentanwälte in Munich, Germany.

See Also